Addus HomeCare (Germany) Today

A41 Stock  EUR 82.50  1.50  1.85%   
A41 falls within the Health Care industry. Cash from operations totals approximately $111.51 million. Short-term liquidity appears adequate with a current ratio near 2.87x, while total assets of roughly $1.44 billion. A41 is priced in euros (EUR), but its financial statements — revenue, earnings, debt, and cash flow — are filed in U.S. dollars (USD). Fundamental figures on this page reflect the USD reporting currency. Price and market capitalization remain in EUR.
Performance
0High
0 · Weak
Odds Of Distress
HighLow
7 · Low
The latest price for Addus HomeCare stands at €82.50, indicating a 1.85% increase in today's trading. Addus HomeCare exhibits forward-looking distress odds of roughly 7%, positioning it within a relatively small probability tier. Over the prior 90 trading days, Addus HomeCare has delivered negative risk-adjusted returns, in line with its weak performance profile. The performance scores window runs from February 8, 2026 to May 9, 2026. Learn more.
 Asset Type
Stock
 Category
Healthcare
 Classification
Health Care
Less Correlated Symbols
  0.74ACT AlzChem Group AGPairCorr
  0.69C6T China Construction BankPairCorr
  0.67B7O CITIC TELECOMPairCorr
  0.64TW10 TENARIS SA DLPairCorr
  0.63XB1 NCAB GROUP ABPairCorr
  0.620MS First Advantage CorpPairCorr
Addus HomeCare (A41) is listed on Frankfurt Exchange in Germany. Addus HomeCare operates within the Health Care Providers & Services segment. Based on a market cap of EUR 1.51 billion, Addus HomeCare ranks in the mid-cap range among health care providers & services. The broader capitalization picture also reflects enterprise value near EUR 1.67 billion, a workforce of about 5,982 people, and about 18.66 million shares outstanding. The elevated P/E of 50.08 combined with ROE of 9.45% may reflect growth expectations beyond current return levels. Addus HomeCare is a professional services provider where revenue is driven by client demand, contract value, and utilization rates. A41 has a beta of 0.4213. With a sub-1 beta, Addus HomeCare typically participates in market rallies at a reduced pace while often limiting downside exposure.
Addus HomeCare financial stability analysis Investment highlights for Addus HomeCare are designed to surface the signals most likely to affect valuation, volatility, and portfolio fit. The practical value is speed: it gathers the most important context before the position is initiated, resized, or compared with peers.
Ownership Allocation The majority of Addus HomeCare's outstanding shares are owned by institutional holders. These positions are typically held by large asset managers, pension funds, and index funds that manage capital on behalf of millions of clients. Institutions of this scale are required to disclose their holdings through 13F filings with the SEC, providing visibility into ownership changes each quarter.
Check Addus HomeCare Ownership Details

Stock Notable Updates

Legal NameAddus HomeCare Corporation
CEO & Chairman of the BoardR Allison
President & COOHeather Dixon
Thematic IdeaFurniture (View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, Furniture, Health Care, Health Care Providers & Services, Medical Care, Healthcare, (View all Sectors)
Financial strength is central to any investment in Addus HomeCare. Investors and stakeholders alike depend on a solid balance sheet and steady cash flow. When applied, this section frames whether current operating momentum is supported by durable balance-sheet quality.
Debt Levels
Addus HomeCare reported $105.7 million in Long Term Debt, $68.2 million in Net Debt, and $1.4 million in Short Long Term Debt. Additional disclosures note $53 thousand in Short Term Debt and a Debt of 352005000, relevant to Addus HomeCare's position within the Health Care sector.

Current Assets

Addus HomeCare reported $780.0 million in Total Assets, $59.2 million in Intangible Assets, and -$18.4 million in Net Tangible Assets. Additional disclosures note $642.5 million in Non Current Assets Total, relevant to Addus HomeCare's position within the Health Care sector.

Addus HomeCare Historical Income Statement

Operating Income stood at $138.62 million as of December 31, 2025. Meanwhile, EBIT is broadly unchanged at $84.57 million, although Total Revenue is broadly unchanged around $1.42 billion. View More Fundamentals

Addus HomeCare Against Markets

Stock Analysis Notes

About 97.0% of A41 shares are held by institutions such as insurance companies. A41 has price-to-book (P/B) ratio of 1.68. Equities trading at this Price to Book (P/B) range reflect investor confidence in earnings power beyond book value. Addus HomeCare has Price/Earnings To Growth (PEG) ratio of 0.96. A41 had not issued any dividends in recent years. Addus HomeCare reported $1.4 billion in Total Assets, $59.2 million in Intangible Assets, and -$18.4 million in Net Tangible Assets.

Gross Profit

$245.9 million
Gross Profit stood at $461.87 million as of December 31, 2025.

Investor Insights and Alerts

Addus HomeCare generated a negative expected return over the last 90 days
Latest headline from news.google.com: Assessing Addus Home Care Valuation After Recent Share Price Recovery And 9 percent Undervaluation Narrative - simplywall.st

Thematic Classifications

Themes linked to Addus HomeCare are useful because they connect a single stock to a larger investable concept that can be researched and optimized as a group. Themes also make it easier to compare substitutes, complements, and diversified extensions of the original idea before capital is allocated.

Market Capitalization

Based on a market cap of EUR 1.51 billion, Addus HomeCare ranks in the mid-cap range among health care providers & services. The broader capitalization picture also reflects enterprise value near EUR 1.67 billion, a workforce of about 5,982 people, and about 18.66 million shares outstanding.

Profitability

Profitability analysis for Addus HomeCare focuses on how well revenue converts into operating income, net income, and free cash flow. Annual revenue is about 1.42 billion. Comparing gross, operating, and net margins isolates where margin strength or pressure originates. A41 has Profit Margin (PM) of 7.0%. Similarly, it shows Operating Margin (OM) of 9.0%.

Management Efficiency

A41 has return on total asset (ROA) of 6.3% a measure of how well capital is deployed. This is broadly in line with industry peers. Addus HomeCare also reports a return on equity (ROE) of 9.45%, a measure of capital efficiency for shareholders.
Management execution at Addus HomeCare is evaluated by whether strategy, financial discipline, and operating results are moving in the same direction. The strongest reading comes from linking leadership decisions to return metrics, balance-sheet quality, and the durability of the business model.
 Operating Margin
9.4%
 Short Long Term Debt
1.39 million
 Operating Margin
9.4%
 Profit Margin
6.9%
 Expected Return
-0.03

Technical Drivers

Pricing data dated the 9th of May indicates Addus HomeCare at 82.50 per share. Recent technical signals highlight risk adjusted performance of 0.0125, and Mean Deviation of 1.91. Trend strength is derived from structured analysis of price and volume distributions. Comparative analysis places current readings within peer ranges.

Price Movement Analysis - Bollinger Bands

Transformation
This analysis covers sixty-one data points across the selected time horizon. The Inverse Tangent (Arctangent) transformation applies the arctangent function to Addus HomeCare's price series, compressing large price values into a bounded range. This can normalize extreme price movements and reveal underlying directional shifts.

Outstanding Bonds

Corporate bonds issued by Addus HomeCare matter because they shape interest expense, maturity risk, and the flexibility management has during tighter credit conditions. At small-cap scale, institutional coverage and secondary-market liquidity are typically well established. Bond investors and equity investors often care about the same cash flows, but they rank the risks differently.

Predictive Daily Indicators

Intraday indicators for Addus HomeCare suit investors who need a shorter decision cycle and tighter control over timing. They help with timing and trade management, but still need to match broader trend and volatility conditions.

Forecast Models

A forecast for Addus HomeCare starts with historical data. Prices often signal trend and momentum shifts before fundamentals catch up. Financial data rarely stays stable for long, so the model is best used as a probability tool, not a price promise.

Stock Overview, Methodology & Data Sources

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas. Addus HomeCare employs 5,982 people. Headquarters are in 6303 Cowboys Way, Frisco, TX, United States, 75034. Recent market snapshot indicates market cap 1.51 billion, P/E 50.08. Addus HomeCare operates in Health Care Providers & Services, Health Care Equipment & Services, Health Care. Operating metrics are tied to how the market is pricing risk. The asset may exhibit relatively defensive behavior during changing market conditions.

Methodology

Unless otherwise specified, financial data for Addus HomeCare is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Addus HomeCare (DE:A41) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. All analytics presented are generated using Macroaxis quantitative models that incorporate financial statement analysis, market data, and risk metrics to ensure consistency and comparability. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Addus HomeCare may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board

Be Your Own Money Manager

Serious investors usually evaluate Addus HomeCare in portfolio context because a good security can still be a weak addition if it increases concentration or unnecessary volatility. The practical goal is to remove redundancy, improve diversification, and keep risk aligned with the intended return target.

Did You Try This?

Run Portfolio Prophet Now

   

Portfolio Prophet

Use AI to generate optimal portfolios and find investment opportunities
All  Next Launch Module

Addus HomeCare Corporate Management

Governance review matters for Addus HomeCare because boards and executives shape oversight, strategic discipline, and how shareholder interests are represented. Institutions hold about 97.24% of shares while insiders own roughly 2.76%.
Sean GaffneyExecutive VP & Chief Legal OfficerProfile
Roberton StevensonExecutive VP & Chief Human Resource OfficerProfile
Diane KumarichSenior Vice President of Payor InnovationProfile
Bradley BickhamPres COOProfile

More Resources for Addus HomeCare Stock Analysis

Value and price for Addus HomeCare are related but not identical, and they can diverge across cycles. For Addus HomeCare, key inputs include a P/E ratio of 50.08, a P/B ratio of 1.68, a profit margin of 6.89%, and ROE of 9.45%.